Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with GLUE: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
GLUE
Monte Rosa Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
GLUE
Monte Rosa Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No disclosed counterparties: GLUE.
Only GLUE
0
None
Role chip = supplier or customer
Source: SEC EDGAR
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
GLUE
Monte Rosa Therapeutics, Inc.
Change
10.57
▲
+3.09%
· post 10.57
Closed
Nov 6 '26
Mkt cap
$875.9M
Revenue
$54M
Q3 FY26
Revenue
$124M
FY25
vs
Compare
Closed
Nov 6 '26
AMGN
Amgen Inc
vs
GLUE
Monte Rosa Therapeutics, Inc.
460.55
▲
+0.06%
post 460.42
Price
10.57
▲
+3.09%
post 10.57
$249.0B
Mkt cap
$875.9M
Q3 FY26
$10.4B
Revenue
$54M
Q3 FY26
FY25
$36.8B
Revenue
$124M
FY25
Change
Change
AMGN
460.55
▲
+0.06%
vs
GLUE
10.57
▲
+3.09%
Closed
Nov 6 '26